CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of PEN 352.82 billion. The enterprise value is 597.06 billion.

Market Cap	352.82B
Enterprise Value	597.06B

Important Dates

The next estimated earnings date is Wednesday, May 6, 2026.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.71%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	88.95%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 59.32 and the forward PE ratio is 10.92.

PE Ratio	59.32
Forward PE	10.92
PS Ratio	0.26
PB Ratio	1.39
P/TBV Ratio	n/a
P/FCF Ratio	13.43
P/OCF Ratio	9.86
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.63, with an EV/FCF ratio of 22.73.

EV / Earnings	100.38
EV / Sales	0.43
EV / EBITDA	9.63
EV / EBIT	16.96
EV / FCF	22.73

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 1.06.

Current Ratio	0.84
Quick Ratio	0.57
Debt / Equity	1.06
Debt / EBITDA	4.53
Debt / FCF	10.24
Interest Coverage	3.21

Financial Efficiency

Return on equity (ROE) is 2.29% and return on invested capital (ROIC) is 5.62%.

Return on Equity (ROE)	2.29%
Return on Assets (ROA)	2.47%
Return on Invested Capital (ROIC)	5.62%
Return on Capital Employed (ROCE)	6.08%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	5.18M
Profits Per Employee	22,921
Employee Count	259,500
Asset Turnover	1.58
Inventory Turnover	18.56

Taxes

In the past 12 months, CVS Health has paid 1.37 billion in taxes.

Income Tax	1.37B
Effective Tax Rate	19.10%

Stock Price Statistics

The stock price has increased by +8.63% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+8.63%
50-Day Moving Average	76.17
200-Day Moving Average	75.45
Relative Strength Index (RSI)	90.91
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.26

Income Statement

In the last 12 months, CVS Health had revenue of PEN 1.35 trillion and earned 5.95 billion in profits. Earnings per share was 4.68.

Revenue	1.35T
Gross Profit	178.74B
Operating Income	33.71B
Pretax Income	7.19B
Net Income	5.95B
EBITDA	49.20B
EBIT	33.71B
Earnings Per Share (EPS)	4.68

Balance Sheet

The company has 35.65 billion in cash and 268.97 billion in debt, giving a net cash position of -233.31 billion.

Cash & Cash Equivalents	35.65B
Total Debt	268.97B
Net Cash	-233.31B
Net Cash Per Share	n/a
Equity (Book Value)	253.60B
Book Value Per Share	199.08
Working Capital	-47.02B

Cash Flow

In the last 12 months, operating cash flow was 35.79 billion and capital expenditures -9.53 billion, giving a free cash flow of 26.26 billion.

Operating Cash Flow	35.79B
Capital Expenditures	-9.53B
Depreciation & Amortization	16.14B
Net Borrowing	-6.23B
Free Cash Flow	26.26B
FCF Per Share	n/a

Margins

Gross margin is 13.29%, with operating and profit margins of 2.51% and 0.44%.

Gross Margin	13.29%
Operating Margin	2.51%
Pretax Margin	0.53%
Profit Margin	0.44%
EBITDA Margin	3.66%
EBIT Margin	2.51%
FCF Margin	1.95%

Dividends & Yields

CVS Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	192.14%
Buyback Yield	-0.71%
Shareholder Yield	-0.71%
Earnings Yield	1.69%
FCF Yield	7.44%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.27 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.27
Piotroski F-Score	7